FORA Capital’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-60,868
| Closed | -$185K | – | 669 |
|
|
2024
Q4 | $185K | Buy |
60,868
+50,501
| +487% | +$154K | 0.02% | 358 |
|
|
2024
Q3 | $53.8K | Buy |
+10,367
| New | +$53.8K | 0.01% | 421 |
|
|
2021
Q3 | – | Sell |
-2,829
| Closed | -$84K | – | 919 |
|
|
2021
Q2 | $84K | Buy |
2,829
+2,145
| +314% | +$63.7K | 0.02% | 629 |
|
|
2021
Q1 | $19K | Sell |
684
-15
| -2% | -$417 | 0.01% | 695 |
|
|
2020
Q4 | $20K | Sell |
699
-4,747
| -87% | -$136K | ﹤0.01% | 873 |
|
|
2020
Q3 | $137K | Buy |
5,446
+1,468
| +37% | +$36.9K | 0.09% | 238 |
|
|
2020
Q2 | $97K | Buy |
3,978
+353
| +10% | +$8.61K | 0.03% | 504 |
|
|
2020
Q1 | $54K | Buy |
+3,625
| New | +$54K | 0.01% | 750 |
|